Canopy Growth Co. (NASDAQ:CGC - Free Report) - Investment analysts at Atb Cap Markets lowered their FY2025 earnings estimates for shares of Canopy Growth in a research note issued on Sunday, February 9th. Atb Cap Markets analyst F. Gomes now forecasts that the company will earn ($2.27) per share for the year, down from their previous estimate of ($2.18). Atb Cap Markets currently has a "Strong Sell" rating on the stock. The consensus estimate for Canopy Growth's current full-year earnings is ($2.38) per share. Atb Cap Markets also issued estimates for Canopy Growth's Q4 2025 earnings at ($0.27) EPS, FY2026 earnings at ($0.73) EPS, FY2027 earnings at ($0.20) EPS, FY2028 earnings at ($0.15) EPS and FY2029 earnings at ($0.08) EPS.
Canopy Growth Price Performance
Shares of NASDAQ CGC remained flat at $1.89 during trading hours on Wednesday. 5,882,043 shares of the company traded hands, compared to its average volume of 7,716,115. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.07 and a current ratio of 1.39. The firm has a market capitalization of $246.51 million, a P/E ratio of -0.38 and a beta of 0.86. The firm's 50 day simple moving average is $2.52 and its two-hundred day simple moving average is $4.05. Canopy Growth has a 1 year low of $1.75 and a 1 year high of $14.92.
Institutional Inflows and Outflows
A number of hedge funds have recently bought and sold shares of CGC. Vontobel Holding Ltd. purchased a new stake in Canopy Growth during the third quarter worth $92,000. Stratos Wealth Advisors LLC purchased a new stake in Canopy Growth during the third quarter worth $97,000. Lake Street Private Wealth LLC boosted its holdings in Canopy Growth by 47.6% during the third quarter. Lake Street Private Wealth LLC now owns 44,638 shares of the company's stock worth $215,000 after buying an additional 14,398 shares in the last quarter. PFG Investments LLC purchased a new stake in Canopy Growth during the third quarter worth $54,000. Finally, Financial Advocates Investment Management purchased a new stake in Canopy Growth during the third quarter worth $57,000. Institutional investors and hedge funds own 3.33% of the company's stock.
About Canopy Growth
(
Get Free Report)
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments.
See Also
Before you consider Canopy Growth, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.
While Canopy Growth currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market volatility creates opportunity. Our analysts have pinpointed 10 stocks perfectly positioned for exceptional growth this spring, even amid economic uncertainty. Don't miss your chance to access this timely research and invest with confidence.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
